PPV23

BIOLOGICAL9 trials

Conditions

DiphtheriaHIV InfectionInfluenza, HumanInvasive Pneumococcal InfectionPertussisPneumococcal InfectionPneumococcal InfectionsPneumonia

Early Phase 1

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

CompletedNCT02515240

University of Toledo Health Science CampusPneumococcal Infection

Start: 2010-07-31End: 2015-03-31Updated: 2015-08-07

PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

CompletedNCT07025876

Jiangsu Province Centers for Disease Control and PreventionStreptococcus Pneumoniae Pneumonia

Start: 2023-11-18End: 2024-07-30Updated: 2025-06-18

Phase 1

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

CompletedNCT05622942

CanSino Biologics Inc.Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections

Start: 2023-03-11End: 2024-01-30Updated: 2024-12-04

Phase 2

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy

CompletedNCT03069703

Assistance Publique - Hôpitaux de ParisInvasive Pneumococcal Infection

Start: 2018-02-05End: 2021-11-21Updated: 2025-11-20

A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)

CompletedNCT06708286

CanSino Biologics Inc.Diphtheria, Pertussis, Tetanus

Start: 2024-12-20End: 2026-03-30Updated: 2026-08-26

Phase 4

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

CompletedNCT02637583

Jena University HospitalPneumococcal Infections

Start: 2017-10-18End: 2023-11-06Updated: 2023-12-01

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

NCT03041051

Aghia Sophia Children's Hospital of AthensHIV Infection

Start: 2015-12-31End: 2017-03-31Updated: 2017-02-02

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

CompletedNCT04559204

China National Biotec Group Company LimitedInfluenza, Human, Pneumonia, Pneumococcal

Start: 2020-09-11End: 2021-10-09Updated: 2022-08-02

PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)

NCT04974294

Liverpool School of Tropical MedicineStreptococcus Pneumonia

Start: 2021-07-28End: 2023-12-31Target: 516Updated: 2023-01-05

Related Papers

Evaluation of the effect of serotype on pneumococcal conjugate vaccine-induced immunity: an exploratory analysis of the PREVENTING PNEUMO 2 trial.

2026-09-15

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)

BMJ Open2022-07-014 citations

Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults

The Journal of Infectious Diseases2018-03-2726 citations

Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults

PLoS ONE2016-03-019 citations